Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 309 results for "wockhardt"

Wockhardt gets High Court approval for scheme of amalgamation

This page uses frames, but your browser doesn't Capital Market, 6 days ago
Wockhardt: Updates on scheme of amalgamation Money Control, 6 days ago

34 images for wockhardt

Sify, 12 hours ago
Business Today India, 1 week ago
NDTV Profit, 1 week ago
Money Control, 1 week ago
India Infoline, 1 week ago
Business Standard, 1 week ago
NewsReality.com, 1 week ago
NDTV Profit, 1 week ago
Business Standard, 1 week ago
APN News, 2 weeks ago
India Infoline

Wockhardt: Final clearance of Chikalthana unit a few quarters away

Investor sentiment in Wockhardt reached its peak on Thursday with likelihood of its Chikalthana plant unit L1 getting FDA clearance soon. This key facility for Wockhardt was the largest contributor to US sales (around $250 million) before getting ...
 Business Standard India1 week ago Wockhardt shares hit fresh 52-week high at Rs 1,980  Smart Investor1 week ago Good Health! Wockhardt soars to fresh 52-week high  India Infoline1 week ago Wockhardt hits 52-week high; zooms 100% in three months  Business Standard India1 week ago
[x]  

Sun Pharma, RComm, Wockhardt to get astro supprort: Gupta

According to Satish Gupta of astrostocktips, pharma stocks like Ranbaxy Laboratories, Sun Pharmaceutical Industries, Wockhardt, Strides Arcolab and Aurobindo Pharma will get astro suppport.
 Money Control4 days ago Tech Mahindra, HCL Tech, Lupin to get astro support: Gupta  Money Control2 months ago Wockhardt, Glenmark to get astro support: Satish Gupta  Money Control2 months ago Pharmaceutical Newsletter - March 16 to 20, 2015  India Infoline1 week ago

Exit Ipca Labs; it's the next Wockhardt in making: Dipan Mehta

In an interview with ET Now, Dipan Mehta, Member BSE & NSE, shares his view on what should investors do with midcap pharma stocks. He advised investors to have a portfolio of pharma stocks instead of picking select midcap names. ET Now: What is ...
 Economic Times4 days ago
Money Today

India's Wockhardt faces mass of lawsuits in U.S. over generic Reglan

Wockhardt's U.S. affiliate must face a mass of suits in a state court over its generic version of the acid reflux drug Reglan (metoclopramide), developed by Wyeth before the firm was bought by Pfizer ($PFE). The court refused to hear an appeal by ...
 Fierce BioMarkers4 days ago We should be able to recover 50-60% sales from Chikalthana: Habil Khorakiwala, Wockhardt  Financial Express1 week ago Wockhardt Expects Early Resolution Of US Export Ban  Businessworld India1 week ago India's Wockhardt, Granules, suggest recent FDA inspections went well  Fierce Biotech Research1 week ago
[x]  

Wockhardt's Daman unit gets UK drug regulator's clearance

The British drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has cleared Wockhardt's Kadaiya facility at Daman, said chairman Habil Khorakiwala.
 DNA1 week ago Wockhardt's Chikalthana unit woes set to abate  DNA1 week ago WOCKHARDT : Regulatory relief, exports boost Wockhardt shares by over 30 per cent  4 Traders1 month ago Regulatory relief, exports boost Wockhardt shares by over 30 per cent  Economic Times1 month ago
[x]  
India Infoline

Wockhardt stock closes 2% higher

The company said that the US health regulator has not found any issues with respect to data security and control measures at Chikalthana plant in its recent inspection. Wockhardt soared to a high of Rs.1,908 after the company said that the US health regulator ...
 India Infoline1 week ago Wockhardt's Chikalthana plant to regain the lost ground soon  Financial Express1 week ago Wockhardt gains on successful inspection of Chikalthana plant  Hindu Business Line1 week ago Wockhardt up 5%, USFDA gives clean chit to Chikalthana unit  Money Control1 week ago
[x]  

Outperform on Wockhardt, target of Rs 1,700

Retain outperform on Wockhardt (WPL) with a 12-month price target of R1,700. While early L1 inspection is a positive, time-line for its eventual clearance remains key which we believe is at least few quarters away. Current margins of WPL is not ...
 Financial Express1 week ago
India Infoline

Wockhardt slips 2.6% on patent refusal for new drug

The stock has slipped over 3.5 per cent in early morning trade on the BSE. Wockhardt is trading in the negative territory this morning on reports of denial of patent for its new drug. According to media reports, the patent office has refused a patent for an ...
 India Infoline1 week ago Wockhardt fails to get patent for osteoarthritis drug  Financial Express1 week ago Patent Office refuses Wockhardt's application related to osteoarthritis drug  Business Standard India1 week ago
[x]  

On FDA demand, Wockhardt revamps quality control team

Wockhardt has put in place a new leadership team to supervise its quality operations, Chairman Habil Khorakiwala said, as the drug-maker continues to face a steady stream of regulatory inspections. Our entire quality team is new, Khorakiwala said, ...
 Hindu Business Line1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - wockhardt
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less